Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare



Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet — manufactured by Trumac Healthcare

Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet

WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India

Salt: Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE*
Form: Tablet
Class: COX-2 NSAID + Gabapentinoid
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ 1 Brand Options

Pricing, brochure & monopoly territory within 24 hrs.

Our Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet Brand Options (1 option)

Trumac Healthcare manufactures and supplies the following Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.

Etocam-PG Tablet

Etocam-PG Tablet

Pack: 10 x 10 (Alu-Alu)

MRP: ₹2500

View Etocam-PG Tablet →

Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.

Therapeutic Indications
  • Chronic low back pain with radicular component
  • Diabetic neuropathy with musculoskeletal pain
  • Post-herpetic neuralgia with inflammation
  • Fibromyalgia (adjunct)
Mechanism of Action

Etoricoxib is a selective COX-2 inhibitor that blocks prostaglandin synthesis at sites of inflammation while sparing the gastric mucosa-protective COX-1 — reducing GI toxicity compared with non-selective NSAIDs. Pregabalin binds alpha-2-delta subunit of voltage-gated calcium channels reducing excitatory neurotransmitter release.

Dosage & Administration
  • Adults: 1 tablet once daily, may increase to twice daily.
Side Effects
  • GI upset (less than non-selective NSAIDs), hypertension, peripheral oedema, headache.
  • Cardiovascular risk with long-term high-dose use.
  • Dizziness, somnolence, weight gain (Pregabalin).
Contraindications
  • Active peptic ulcer or GI bleeding.
  • Severe heart failure.
  • Uncontrolled hypertension.
  • Severe hepatic/renal impairment.
  • Pregnancy (third trimester).
  • Aspirin-triggered asthma.
  • Severe renal impairment (Pregabalin dose adjustment).
Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise for Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet

  • ✓ WHO-GMP certified manufacturing facility
  • ✓ Pan-India monopoly distribution rights available
  • ✓ Multiple pack sizes: 10 x 10 (Alu-Alu)
  • ✓ Trade-friendly PTR / PTS margins
  • ✓ Free promotional material on request
  • ✓ Full DCGI documentation and quality certificates supplied

Trumac Healthcare offers 1 brand option for Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.

For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.

Frequently Asked Questions

Who is the manufacturer of Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet?

Trumac Healthcare is a WHO-GMP certified manufacturer of Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.

Is Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet available for PCD pharma franchise on monopoly basis?

Yes. We offer Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.

What pack sizes are available for Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet?

Available pack sizes include: 10 x 10 (Alu-Alu).

What is the MRP / trade price for Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet?

MRPs range from ₹2500 to ₹2500 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.

How do I place an order or franchise enquiry?

WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.

Ready to start your PCD franchise for Etoricoxib 60 mg + Pregabalin 75 mg (SR) *DCGI APPROVED MOLECULE* Tablet?

Get Pricing & Franchise Terms →